These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9455500)
21. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies. Odum N; Ledbetter JA; Martin P; Geraghty D; Tsu T; Hansen JA; Gladstone P Eur J Immunol; 1991 Sep; 21(9):2121-31. PubMed ID: 1889460 [TBL] [Abstract][Full Text] [Related]
22. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Varney MD; Lester S; McCluskey J; Gao X; Tait BD Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803 [TBL] [Abstract][Full Text] [Related]
23. Polymorphism in the regulatory regions of the HLA-DPB1 gene. Varney MD; Gavrilidis A; Tait BD Hum Immunol; 1999 Oct; 60(10):955-61. PubMed ID: 10566595 [TBL] [Abstract][Full Text] [Related]
24. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830. Mariani SM; Armandola EA; Ferrone S J Immunol; 1991 Aug; 147(4):1322-30. PubMed ID: 1714480 [TBL] [Abstract][Full Text] [Related]
25. New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells. Cayrol C; Moro F; Sommer E; Tkaczuk J; Ohayon E; Cambon-Thomsen A Tissue Antigens; 1992 Oct; 40(4):197-203. PubMed ID: 1281933 [TBL] [Abstract][Full Text] [Related]
26. HLA-DPbeta residue 69 plays a crucial role in allorecognition. Díaz G; Catálfamo M; Coiras MT; Alvarez AM; Jaraquemada D; Nombela C; Sánchez-Pérez M; Arroyo J Tissue Antigens; 1998 Jul; 52(1):27-36. PubMed ID: 9714471 [TBL] [Abstract][Full Text] [Related]
27. HLA-DPA1 and DPB1 polymorphism in four Pacific Islands populations determined by sequencing based typing. Velickovic ZM; Carter JM Tissue Antigens; 2001 Jun; 57(6):493-501. PubMed ID: 11556979 [TBL] [Abstract][Full Text] [Related]
28. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens. Schütt C; Horejsi V; Walzel H; Siegl E Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743 [TBL] [Abstract][Full Text] [Related]
29. Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe. Voorter CE; Groeneweg M; Joannis MO; Meertens C; Agis F; Tilanus MG Tissue Antigens; 2014 Mar; 83(3):147-53. PubMed ID: 24405442 [TBL] [Abstract][Full Text] [Related]
30. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941 [TBL] [Abstract][Full Text] [Related]
31. Characterization of monoclonal antibodies directed against HLA class II molecules. Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773 [TBL] [Abstract][Full Text] [Related]
32. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis. Yoshino T; Cao L; Nishiuchi R; Matsuo Y; Yamadori I; Kondo E; Teramoto N; Hayashi K; Takahashi K; Kamikawaji N Eur J Immunol; 1995 Aug; 25(8):2190-4. PubMed ID: 7545111 [TBL] [Abstract][Full Text] [Related]
33. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues. Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553 [TBL] [Abstract][Full Text] [Related]
34. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain. el-Zaatari FA; Sams KC; Taurog JD J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355 [TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells. Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326 [TBL] [Abstract][Full Text] [Related]
36. The role of HLA-DP beta residue 69 in the definition of antibody-binding epitopes. Arroyo J; Alvarez AM; Nombela C; Sánchez-Pérez M Hum Immunol; 1995 Jul; 43(3):219-26. PubMed ID: 7558939 [TBL] [Abstract][Full Text] [Related]
37. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Schaffer M; Aldener-Cannavá A; Remberger M; Ringdén O; Olerup O Tissue Antigens; 2003 Sep; 62(3):243-50. PubMed ID: 12956878 [TBL] [Abstract][Full Text] [Related]
38. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594 [TBL] [Abstract][Full Text] [Related]
39. R1-20, a novel monoclonal antibody reacting with a molecule distinct from integrin family, induces homotypic cell aggregation. Nakamura S; Imanishi J; Minowada J J Immunol; 1992 Jul; 149(1):30-7. PubMed ID: 1607659 [TBL] [Abstract][Full Text] [Related]
40. Use of transfectants to characterize a monoclonal antibody recognizing a monomorphic DR beta-chain epitope shared by some DQ and DP molecules. Cayrol C; Moro F; Tkaczuk J; Cambon-Thomsen A Tissue Antigens; 1993 Apr; 41(4):196-9. PubMed ID: 7689765 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]